Insider trading

Period: 120 months Stock: NKTR Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

61 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

61 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

61 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

61 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
61 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
61 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

61 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
4 Feb 2021
ROBIN HOWARD W President & CEO
Sold, plan not stated 2×
$3.04M 150,000 at 20.29
24.6%
3 Feb 2021
ROBIN HOWARD W President & CEO
Sold, plan not stated
$2.96M 150,000 at 19.72
24.6%
2 Feb 2021
ROBIN HOWARD W President & CEO
Sold, plan not stated 3×
$2.97M 150,000 at 19.77
24.6%
2 Feb 2021
Labrucherie Gil M SVP, COO & CFO
Sold, plan not stated 3×
$1.01M 50,000 at 20.17
15.8%
28 Jan 2021
Thomsen Jillian B. SVP & Chief Accounting Officer
Sold, plan not stated
$1.40M 75,000 at 18.62
29.8%
24 Jul 2019
ROBIN HOWARD W President & CEO
Sold, plan not stated
$1.07M 33,334 at 32.11
10.1%
23 Jul 2019
ROBIN HOWARD W President & CEO
Sold, plan not stated
$1.07M 33,333 at 32.10
10.1%
23 May 2019
ROBIN HOWARD W President & CEO
Sold, plan not stated
$1.09M 33,333 at 32.69
10.1%
22 May 2019
ROBIN HOWARD W President & CEO
Sold, plan not stated
$1.11M 33,334 at 33.38
10.1%
21 May 2019
ROBIN HOWARD W President & CEO
Sold, plan not stated
$1.10M 33,333 at 32.93
10.1%
21 Feb 2019
ROBIN HOWARD W President & CEO
Sold, plan not stated
$1.37M 33,333 at 41.01
9.7%
20 Feb 2019
ROBIN HOWARD W President & CEO
Sold, plan not stated
$1.44M 33,334 at 43.20
9.7%
19 Feb 2019
ROBIN HOWARD W President & CEO
Sold, plan not stated 2×
$1.79M 42,215 at 42.33
12.0%
28 Jan 2019
Nicholson John SVP & Chief Operating Officer
Sold, plan not stated
$2.70M 63,000 at 42.82
26.5%
14 Aug 2018
WINGER DENNIS L Director
Sold, plan not stated
$1.03M 17,125 at 60.15
28.6%
13 Aug 2018
WINGER DENNIS L Director
Sold, plan not stated
$1.05M 17,125 at 61.04
22.2%
27 Jun 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$2.05M 43,333 at 47.39
16.2%
26 Jun 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$2.14M 43,333 at 49.36
16.2%
25 Jun 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$2.25M 43,334 at 51.82
16.2%
16 May 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$1.07M 12,791 at 83.39
5.4%
3 May 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$3.59M 43,333 at 82.86
15.4%
3 May 2018
Labrucherie Gil M SVP & Chief Financial Officer
Sold, plan not stated
$2.49M 30,000 at 82.86
23.1%
3 May 2018
CHESS ROBERT Director
Sold, plan not stated 2×
$2.07M 25,000 at 82.80
8.4%
2 May 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$3.71M 43,333 at 85.63
15.4%
2 May 2018
Labrucherie Gil M SVP & Chief Financial Officer
Sold, plan not stated
$2.57M 30,000 at 85.63
23.1%
1 May 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$3.62M 43,334 at 83.65
15.4%
1 May 2018
Labrucherie Gil M SVP & Chief Financial Officer
Sold, plan not stated
$2.51M 30,000 at 83.65
23.1%
16 Apr 2018
Thomsen Jillian B. SVP & Chief Accounting Officer
Sold, plan not stated
$1.41M 13,881 at 101.46
16.8%
9 Apr 2018
Doberstein Stephen K SVP & Chief Scientific Officer
Sold, plan not stated
$4.76M 49,500 at 96.13
42.3%
6 Apr 2018
Doberstein Stephen K SVP & Chief Scientific Officer
Sold, plan not stated
$10.13M 110,500 at 91.69
62.1%
Sold half or more
6 Apr 2018
GREER R SCOTT Director
Sold, plan not stated
$2.77M 30,000 at 92.22
18.7%
6 Apr 2018
CHESS ROBERT Director
Sold, plan not stated 2×
$2.30M 25,000 at 92.14
8.4%
5 Apr 2018
Lingnau Lutz Director
Sold, plan not stated
$3.05M 30,000 at 101.74
52.2%
Sold half or more
5 Apr 2018
Hora Maninder SVP Pharma Dev & Mfg Ops
Sold, plan not stated
$2.04M 20,000 at 101.75
19.9%
7 Mar 2018
Nicholson John SVP & Chief Operating Officer
Sold, plan not stated
$10.06M 100,144 at 100.45
37.4%
7 Mar 2018
Sold, plan not stated
$3.64M 37,400 at 97.41
48.0%
6 Mar 2018
Nicholson John SVP & Chief Operating Officer
Sold, plan not stated
$11.79M 120,000 at 98.29
31.0%
16 Feb 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$1.06M 12,788 at 82.94
5.1%
22 Jan 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$6.32M 83,333 at 75.82
25.0%
2 Jan 2018
Sold, plan not stated
$1.76M 30,000 at 58.66
42.6%
13 Dec 2017
ROBIN HOWARD W President & CEO
Sold, plan not stated
$4.64M 83,333 at 55.69
30.6%
8 Nov 2017
Doberstein Stephen K SVP & Chief Scientific Officer
Sold, plan not stated
$9.03M 300,000 at 30.09
90.6%
Sold half or more
7 Nov 2017
Doberstein Stephen K SVP & Chief Scientific Officer
Sold, plan not stated
$1.94M 75,409 at 25.78
70.8%
Sold half or more
1 Nov 2017
ROBIN HOWARD W President & CEO
Sold, plan not stated
$1.96M 83,334 at 23.57
35.3%
9 Oct 2017
ROBIN HOWARD W President & CEO
Sold, plan not stated
$2.02M 83,333 at 24.20
35.3%
5 Oct 2017
Doberstein Stephen K SVP & Chief Scientific Officer
Sold, plan not stated
$1.09M 43,677 at 24.97
58.4%
Sold half or more
2 Oct 2017
Labrucherie Gil M SVP & Chief Financial Officer
Sold, plan not stated
$2.93M 120,000 at 24.45
65.4%
Sold half or more
2 Oct 2017
Gergel Ivan P. SVP & Chief Medical Officer
Sold, plan not stated
$1.37M 56,704 at 24.21
57.7%
Sold half or more
29 Sep 2017
Gergel Ivan P. SVP & Chief Medical Officer
Sold, plan not stated
$1.04M 43,296 at 24.04
51.0%
Sold half or more
6 Sep 2017
ROBIN HOWARD W President & CEO
Sold, plan not stated
$1.79M 83,333 at 21.54
35.3%
Showing 1–50 of 61. Page 1 of 2 Older →